Multiomic Health

📍 London, United Kingdom🗓 Founded 2021👥 22 employees💰 Last funded May 2023
Biotechnology Research🌐 multiomic.health
Website LinkedIn
Multiomic Health is a data-centric therapeutics venture, writing the latest chapter of the precision medicine story by tackling a global, trillion dollar healthcare problem: metabolic syndrome-related conditions (atherosclerotic cardiovascular disease, type 2 diabetes, chronic kidney disease and non-alcoholic fatty liver). Our mission is to transform patient health outcomes with precision medicines that go beyond the one-size-fits-all approach currently dominating this disease space. We apply advanced computational systems biology modelling and AI-enabled predictive analytics on deep, standardised patient datasets. These datasets feed into a data lake of thousands of patients, featuring millions of data points per patient accumulated from a wide spectrum of omics, rich clinical phenotyping and various tissue types collected over multiple time points. We use our proprietary MOHSAIC® platform to identify unique patient endotypes, re-position existing drug candidates and discover novel drug targets, leading to breakthrough precision therapeutics for the world’s largest patient population.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
2
Frequently asked questions
Who invested in Multiomic Health?
Multiomic Health has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Multiomic Health last raise funding?
The most recent investment in Multiomic Health recorded on gritt.io was in May 2023.
When was Multiomic Health founded?
Multiomic Health was founded in 2021.
What industry is Multiomic Health in?
Multiomic Health operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Multiomic Health based?
Multiomic Health is headquartered in London, United Kingdom.